Cardisio
Frankfurt
About Cardisio
Cardisio is a mobile health tech company that uses artificial intelligence in a non-invasive screening test for coronary and structural heart diseases. The Cardisiography test can detect heart disease early, allowing for preventive treatment to avoid a potentially fatal heart attack. Cardisiography analyzes the individual three-dimensional electrophysical profile of the heart and recognizes pathological patterns of heart diseases using a proprietary algorithm and neural networks (AI). The test requires a PC to access the web service (Cardisio Cloud), a data collector (e.g. a Cardisiograph), and commercially available ECG cables as well as five disposable electrodes.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $9.7M
- Last round: Grant (Jan 2023)
- Website: cardis.io
- Phone: [email protected]
Industries & Categories
Artificial Intelligence (AI), Fitness, Health Care, Wellness
Social Profiles
Canonical: https://fsome.com/organization/cardisio-53031 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.